Skip to main content
. 2016 Jan 4;4(6):1150–1155. doi: 10.1039/c5tb01810b

Fig. 3. Cell viability of human cervical cancer cells (HeLa) after exposure to free doxorubicin hydrochloride or Au@PEG-INU/Doxo NPs, for either 48 h or 72 h.

Fig. 3